Middle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013

被引：15
作者：
Lim, Poh Lian [1 ,2 ]
Lee, Tau Hong [1 ]
Rowe, Emily K. [1 ]
机构：
[1] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore
[2] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore
来源：
CURRENT INFECTIOUS DISEASE REPORTS | 2013年 / 15卷 / 04期
关键词：
Middle East Respiratory Syndrome coronavirus (MERS CoV); Coronavirus; Respiratory illness; SARS; PNEUMONIA;
D O I：
10.1007/s11908-013-0344-2
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Middle East Respiratory Syndrome coronavirus (MERS CoV) came to attention as an emerging pathogen causing severe respiratory illness in patients from the Middle East in September 2012. As of 14 June 2013, 58 human cases of MERS CoV infection have been confirmed, including 33 deaths (case fatality rate of 57%). MERS CoV is a betacoronavirus, in the same family as SARS-CoV, and shares a probable origin from bats. No animal reservoir or intermediates have been definitely implicated in transmission. Limited human-to-human transmission has occurred within several clusters, as individuals without a recent travel history have become infected after exposure to an ill returned traveler.
引用
收藏
页码：295 / 298
页数：4
相关论文
共 50 条
  • [31] THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) - WHAT IS THE RISK? A REVIEW OF RECENT STUDIES
    Jozefiak, Agata
    Wozniak, Mariusz
    Jaskowski, Jegdrzej M.
    ANNALS OF ANIMAL SCIENCE, 2015, 15 (04): : 833 - 848
  • [32] Middle east respiratory syndrome corona virus (MERS CoV): The next steps
    Joseph, Iype
    JOURNAL OF PUBLIC HEALTH POLICY, 2015, 36 (03) : 318 - 323
  • [33] Molecular dynamics of Middle East Respiratory Syndrome Coronavirus (MERS CoV) fusion heptad repeat trimers
    Kandeel, Mahmoud
    Al-Taher, Abdulla
    Li, Huifang
    Schwingenschlogl, Udo
    Al-Nazawi, Mohamed
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2018, 75 : 205 - 212
  • [34] Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
    Lu, Lu
    Liu, Qi
    Du, Lanying
    Jiang, Shibo
    MICROBES AND INFECTION, 2013, 15 (8-9) : 625 - 629
  • [35] Middle East Respiratory Syndrome Coronavirus: Update for Clinicians
    Rasmussen, Sonja A.
    Gerber, Susan I.
    Swerdlow, David L.
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (11) : 1686 - 1689
  • [36] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) coinfection: A unique case series
    Elhazmi, Alyaa
    Al-Tawfiq, Jaffar A.
    Sallam, Hend
    Al-Omari, Awad
    Alhumaid, Saad
    Mady, Ahmad
    Al Mutair, Abbas
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 41
  • [37] An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    Biswas, Suvro
    Mita, Mohasana Akter
    Afrose, Shamima
    Hasan, Md. Robiul
    Shimu, Mst. Sharmin Sultana
    Zaman, Shahriar
    Abu Saleh, Md.
    HELIYON, 2024, 10 (04)
  • [38] Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart
    Cauchemez, S.
    Van Kerkhove, M. D.
    Riley, S.
    Donnelly, C. A.
    Fraser, C.
    Ferguson, N. M.
    EUROSURVEILLANCE, 2013, 18 (24): : 7 - 13
  • [39] Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak perceptions of risk and stress evaluation in nurses
    Bukhari, Elham Essa
    Temsah, Mohamad Hani
    Aleyadhy, Ayman A.
    Alrabiaa, Abdulkareem A.
    Alhboob, Ali An
    Jamal, Amr A.
    Binsaeed, Abdulaziz A.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (08): : 845 - 850
  • [40] Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: How Close Are We?
    Ali S. Omrani
    Ziad A. Memish
    Current Treatment Options in Infectious Diseases, 2015, 7 (3) : 202 - 216
12345